Misonix Reports Record Quarterly Revenue of $19.7 Million for Fiscal 2020 Second Quarter
05 févr. 2020 16h05 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2020 Second Quarter Financial Results And Host Conference Call and Webcast on February 5
27 janv. 2020 17h00 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Announces Pricing of Public Offering of Common Stock
23 janv. 2020 08h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Announces Public Offering of Common Stock
22 janv. 2020 16h01 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 Million
13 janv. 2020 08h05 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Present at 38th Annual J.P. Morgan Healthcare Conference
17 déc. 2019 08h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Announces Results of New Large Real-World Studies That Further Prove the Clinical Effectiveness of TheraSkin
05 déc. 2019 09h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Fiscal 2020 First Quarter Record Quarterly Product Revenue Of $11.1 Million
07 nov. 2019 16h05 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Participate in Three Upcoming Investor Conferences
04 nov. 2019 08h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2020 First Quarter Financial Results and Host Conference Call and Webcast on November 7
28 oct. 2019 08h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...